RT Journal Article
SR Electronic
T1 Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001089
DO 10.1136/jitc-2020-001089
VO 8
IS 2
A1 Montesarchio, Vincenzo
A1 Parrella, Roberto
A1 Iommelli, Chiara
A1 Bianco, Antonella
A1 Manzillo, Elio
A1 Fraganza, Fiorentino
A1 Palumbo, Cristiana
A1 Rea, Gaetano
A1 Murino, Patrizia
A1 De Rosa, Rosanna
A1 Atripaldi, Luigi
A1 D’Abbraccio, Maurizio
A1 Curvietto, Marcello
A1 Mallardo, Domenico
A1 Celentano, Egidio
A1 Grimaldi, Antonio Maria
A1 Palla, Marco
A1 Trojaniello, Claudia
A1 Vitale, Maria Grazia
A1 Million-Weaver, Samuel Lewis
A1 Ascierto, Paolo Antonio
YR 2020
UL http://jitc.bmj.com/content/8/2/e001089.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.